Company overview
Phesi provides AI-driven patient-centric data analytics through its Trial Accelerator platform, simulating clinical trials with data from over 132 million patients across 4,000 diseases and 485,000 trials. The platform supports protocol design, site selection, patient enrollment forecasting, and digital twins for external control arms to optimize trial efficiency and diversity. Trusted by leading pharmaceutical companies, it accelerates development for rare and common indications in nearly 200 countries.
Phesi is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services partner serving United States & Americas. Core focus areas include clinical trial analytics, ai trial simulation, patient-centric data, protocol optimization, site selection pharma.
Industry categories: CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.phesi.com
- Categories
- CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- clinical trial analytics, ai trial simulation, patient-centric data, protocol optimization, site selection pharma
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What is Phesi's Trial Accelerator platform?
- Trial Accelerator is an AI-powered platform with data from 132 million patients, enabling simulation of trial design, protocol optimization, enrollment forecasting, and patient diversity analysis across 4,000 diseases and 485,000 trials.
- What clinical development services does Phesi offer?
- Services include protocol design, site selection, patient enrollment modeling, digital patient profiles, digital twins, and external control arms, covering the full clinical development workflow from planning to execution.
- What geographic coverage and data scale does Phesi provide?
- Phesi covers nearly 200 countries with trial and site data from 600,000 principal investigators, drawing from over 70,000 real-time sources including clinical trials and real-world patient records.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
